← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Enovix Corp: Revenue grew 37.9% to $31.82M from $23.07M. Net loss narrowed to $157M from $222M. Free cash flow outflow narrowed to $114M from $185M. Operating margin expanded 49467 bps to -557.03%. Enovix Corp's annual comparison also shows inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 37.9% to $31.82M from $23.07MOK
- Profitability — Net loss narrowed to $157M from $222MOK
- Cash flow — Free cash flow outflow narrowed to $114M from $185MOK
- Margins — Operating margin expanded 49467 bps to -557.03%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 3 salesWatch
Business
Business Company Overview Enovix Corporation (the "Company," "we," "us," "our" and "Enovix") is a global high-performance battery company focused on designing, developing, manufacturing, and commercializing advanced Lithium-ion, or Li-ion, batteries, including proprietary silicon-anode architectures, for smartphones, smart eyewear, defense, industrial and emerging edge-AI applications.
Where the revenue comes from
Fiscal 2025, as Enovix Corp reports it. History and quarterly detail are in the app.
Leadership changes
From Enovix Corp's own filings, the day they're filed.
- John Daniel · directors · appointmenteff. 2025-08-12
- Ryan Benton · Chief Financial Officer · appointmenteff. 2025-04-14
- Kristina Truong · President · appointmenteff. 2024-12-30
Latest filings
- 8-K · Company announcement2026-08-17
- 8-K · Company announcement2026-08-12
- 10-Q · Quarterly report2026-08-12
- 8-K · Company announcement2026-07-09
- 8-K · Company announcement2026-06-12
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Enovix Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.